| Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725) |
|---|
| 01/22/2003 | EP0729465B1 Pyrone derivatives as protease inhibitors and antiviral agents |
| 01/22/2003 | CN1099420C Substituted spiroheterocyclic 1H-3-arylpyrrolidine-2-4,-dione derivatives, methods of preparing them and their use as pest-control agents |
| 01/21/2003 | US6509369 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
| 01/21/2003 | US6509362 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis. |
| 01/16/2003 | US20030013756 Hormone inhibitor; sexual disorders |
| 01/16/2003 | US20030013702 Agents and methods for treatment of cancer |
| 01/16/2003 | US20030012803 E.g., ethyl 3-methyl-5-(,5,8,8-tetra-methyl-5,6,7,8-tetra-hydronaphthalen-2 -ylselenyl)pent-2-en-4-ynoate; dermatological, rheumatic, respiratory, cardiovascular and ophthalmological uses as well as cosmetic uses |
| 01/15/2003 | EP1274700A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 01/15/2003 | EP1274456A2 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies |
| 01/15/2003 | EP0790989B1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/09/2003 | WO2003002557A1 Novel compounds for use as photoinitiators |
| 01/09/2003 | WO2003002202A1 Antitumoral formulations of thioxanthenone |
| 01/09/2003 | CA2451195A1 Antitumoral formulations of thioxanthenone |
| 01/02/2003 | EP1270565A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives |
| 01/02/2003 | EP1270554A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 01/02/2003 | EP1270553A2 Acid generator, sulfonic acid, sulfonic acid derivatives and radiation-sensitive resin composition |
| 01/02/2003 | EP1268464A1 Radioisotope-labeled complexes of glucose derivatives and kits for the preparation thereof |
| 01/01/2003 | CN1097588C Dihydrobenzofuran and related compounds used as anti-inflammatory agents |
| 12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 12/19/2002 | WO2002100813A2 Modulators of peroxisome proliferator activated receptors |
| 12/19/2002 | US20020193578 Compounds having activity as inhibitors of cytochrome P450RAI |
| 12/19/2002 | US20020193403 Administering retinoic acid receptors (RAR) antagonist or an RAR inverse agonist for therapy of hyperlipidemia in mammal |
| 12/19/2002 | US20020193354 7, 9-substituted tetracycline compounds |
| 12/19/2002 | CA2449256A1 Modulators of peroxisome proliferator activated receptors |
| 12/18/2002 | EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 12/18/2002 | EP1265848A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 12/17/2002 | US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |
| 12/11/2002 | CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 12/10/2002 | US6492396 Substituted thioacetamides |
| 12/10/2002 | US6492390 Treating cyclooxygenase-2 mediated disorders. |
| 12/05/2002 | WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 12/05/2002 | US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder |
| 12/05/2002 | US20020182535 Resolution, sensitivity and smoothness on side surfaces of a transferred pattern; photolithography |
| 12/05/2002 | DE10126434A1 New tricyclic thiochromenone derivatives as metabotropic glutamate receptor-1 (mGluR1) antagonists useful for treating e.g. hemorrhagic stroke and atherosclerosis, especially pain or neurodegenerative diseases |
| 12/05/2002 | CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 12/04/2002 | EP1100769B1 Aminomethylcarboxylic acid derivatives |
| 11/21/2002 | WO2002092594A1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 11/21/2002 | WO2002092552A2 Benzamidoacetonitriles and their use as antiparasitics |
| 11/21/2002 | WO2002092076A1 Substituted coumarins and quinolines as caspases activators |
| 11/21/2002 | CA2447084A1 Benzamidoacetonitriles and their use as antiparasitics |
| 11/19/2002 | US6482950 Squarylium compounds, and processes and intermediates for the synthesis of these compounds |
| 11/19/2002 | CA2061706C Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis |
| 11/14/2002 | WO2002089781A2 Methods of treating hyperlipidemia |
| 11/14/2002 | CA2445504A1 Methods of treating hyperlipidemia |
| 11/13/2002 | EP1256576A1 Fused imidazolium derivatives |
| 11/13/2002 | CN1379769A Novel composition and method or stabilizing same |
| 11/12/2002 | US6479670 Selective retinoid acid receptor agonists |
| 11/12/2002 | US6479495 Simultaneously treating depression and memory dysfunction in mammals suffering from memory dysfunction and depression |
| 11/12/2002 | US6479489 Substituted spiroheterocyclic 1H-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents |
| 11/07/2002 | US20020165096 Applying to weeds |
| 11/07/2002 | US20020164577 Detection of transmembrane potentials by optical methods |
| 11/06/2002 | EP0781280B1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors |
| 11/05/2002 | US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 10/24/2002 | US20020156054 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 10/22/2002 | US6469028 Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities |
| 10/17/2002 | WO2002080841A2 Antibacterial oxazolidinones with a cyclic sulphilimine or sulphoximine |
| 10/16/2002 | EP1248777A2 Tricyclic compounds with antiviral activity |
| 10/16/2002 | EP1248602A2 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
| 10/15/2002 | US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate |
| 10/10/2002 | WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 10/10/2002 | WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 10/10/2002 | US20020147342 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors |
| 10/10/2002 | CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications |
| 10/09/2002 | EP0944613B1 Benzopyran derivatives |
| 10/09/2002 | EP0900237B1 Photoactive compounds for use with narrow wavelength band ultraviolet (uv) curing systems |
| 10/08/2002 | US6462198 Used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia, |
| 10/08/2002 | US6462055 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 10/03/2002 | WO2002076395A2 Agents and methods for treatment of cancer |
| 10/03/2002 | CA2441394A1 Agents and methods for treatment of cancer |
| 10/02/2002 | EP1151021A4 Initiator compositions and methods for their synthesis and use |
| 10/02/2002 | CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection |
| 10/01/2002 | US6458967 Method for preparation of an intermediate dye product |
| 09/26/2002 | US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma |
| 09/26/2002 | US20020137201 Detection of transmembrane potentials by optical methods |
| 09/25/2002 | EP1070059B1 Chromanone and thiochromanone derivatives |
| 09/19/2002 | WO2002072532A1 7, 9-substituted tetracycline compounds |
| 09/19/2002 | US20020133024 Aromatic carboxylic acid bicyclic sulfur compounds |
| 09/19/2002 | US20020132796 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |
| 09/18/2002 | EP1241167A1 3-ethyl-, 3-propyl- or 3-butyl-chroman and -thiochroman derivatives |
| 09/18/2002 | EP1241166A1 3-methyl-chroman and -thiochroman derivatives |
| 09/18/2002 | EP1241165A1 Optically active chroman and thiochroman derivatives |
| 09/18/2002 | EP1240156A1 3-methyl-chromane or thiochromane derivatives |
| 09/18/2002 | EP1240155A1 Metal salts of 3-methyl-chromane or thiochromane derivatives |
| 09/18/2002 | CN1370156A Benzopyrans and benzothiopyrans as RAR selective retinoid agonists |
| 09/12/2002 | WO2002070516A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 09/04/2002 | CN1367777A Benzenamine derivatives as anti-coagulants |
| 09/04/2002 | CN1367775A Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 09/03/2002 | US6444709 Skin disorders; antiinflammatory agents; antiarthritic agents; cardiovascular disorders |
| 08/29/2002 | US20020120168 Difluoromethyl ether derivative and process for producing the same |
| 08/28/2002 | EP0848696B1 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 08/28/2002 | CN1089749C Pesticidal hydrazide derivatives |
| 08/27/2002 | US6441010 Bi-aromatic compounds linked via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing them |
| 08/27/2002 | US6440899 Cyclohexenonedioxothiochromanoyl derivatives |
| 08/22/2002 | US20020115079 Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis |
| 08/15/2002 | WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 08/13/2002 | US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents |
| 08/08/2002 | US20020107264 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups |
| 08/07/2002 | EP1229033A2 2-Fluoro-(oxid-thiopyran-4-yl)benzene derivatives |
| 08/07/2002 | EP0986537B1 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |